Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Cancer Cells and Metastasis, Viral-associated cancers and disorders, and Acute Myeloid Leukemia Research.
Atherosclerosis enhances the efficacy of liposome-encapsulated bromocriptine in reducing the incidence of prolactinemia in pituitary tumors
Toward Fully Integrated Microneedle Sensors: Advances and Challenges in Personalized Health Monitoring and Drug Delivery
Precision Pathology of Cancer
Author Correction: Synergistic suppression of noscapine and conventional chemotherapeutics on human glioblastoma cell growth.
Comment on "A Novel <i>COL1A1-CAMTA1</i> Rearrangement in Cranial Fasciitis".
Mizuho hemoglobinopathy, presenting with severe hemolytic anemia and multisystem organ failure secondary to exertion.
Critical role of ASCT2-mediated amino acid metabolism in promoting leukaemia development and progression
Critical role of ASCT2-mediated amino acid metabolism in promoting leukaemia development and progression.
Long non-coding RNA CDKN2B-AS1 reduces inflammatory response and promotes cholesterol efflux in atherosclerosis by inhibiting ADAM10 expression
Downregulation of DLGAP1-Antisense RNA 1 Alleviates Vascular Endothelial Cell Injury Via Activation of the Phosphoinositide 3-kinase/Akt Pathway Results from an Acute Limb Ischemia Rat Model
Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis
Compartment-Dependent Degradation of Mutant Huntingtin Accounts for Its Preferential Accumulation in Neuronal Processes
Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage
SIRT3 Enhances Glycolysis and Proliferation in SIRT3-Expressing Gastric Cancer Cells
Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells
Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells
HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells